Media & Press

In US News and World Report, neurologist Daniel Hanley discusses a new treatment protocol for intracerebral hemorrhage which dramatically improves bleeding stroke outcomes.

A clinical trial conducted by Dr. Douglas Kerr and his team reveals a new immunosuppressant treatment for MS with great promise. Click here to read the press release.

Neurosurgeon Michael Lim discusses a rare intracranial hypotension case in the Baltimore Sun. Click here to read article.

Neurosurgeon Jon Weingart explains the most common types of brain tumors, treatments and cutting edge research that may help in their treatment. Listen to podcast > >

Read Justin McArthur's "State of the Department Address" for the Department of Neurology, 2007.

Press Releases

Epilepsy
Modified Atkins Diet Can Reduce Epileptic Seizures in Adults

Multiple Sclerosis
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS).

Stroke
A multicenter study led by Johns Hopkins doctors has fine-tuned the dosage and timing for administering clot-busting tissue plasminogen activator (tPA) to patients with strokes caused by bleeding within the brain.

Transverse Myelitis
Johns Hopkins Researchers Discover Key Protein Linked To Transverse Myelitis and Multiple Sclerosis

Media Coverage

Pediatric Neurosurgery
Separation Surgery: Read the story of conjoined twins who underwent separation surgery at Johns Hopkins.

Read about a young child who recieved treatment for a slow-growing tumor within her spinal cord, an intramedullary astrocytoma, here at Johns Hopkins. [PDF]

Transverse Myelitis
Hear Doug Kerr and Cody Unser discuss Transverse Myelitis and stem cell research on the CBS Early Show here>>